Market Research Logo

Cumberland Pharmaceuticals Inc (CPIX) - Financial and Strategic SWOT Analysis Review

Cumberland Pharmaceuticals Inc (CPIX) - Financial and Strategic SWOT Analysis Review

- provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

  • Business description – A detailed description of the company’s operations and business divisions.
  • Corporate strategy – Analyst’s summarization of the company’s business strategy.
  • SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
  • Company history – Progression of key events associated with the company.
  • Major products and services – A list of major products, services and brands of the company.
  • Key competitors – A list of key competitors to the company.
  • Key employees – A list of the key executives of the company.
  • Executive biographies – A brief summary of the executives’ employment history.
  • Key operational heads – A list of personnel heading key departments/functions.
  • Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
  • Key manufacturing facilities – A list of key manufacturing facilities of the company.
  • Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
  • Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
Highlights

Cumberland Pharmaceuticals Inc (Cumberland Pharma) is a specialty pharmaceutical company that acquires, develops and commercializes branded prescription products. Its primary target markets are hospital acute care, gastroenterology and cancer supportive care. The company offers branded prescription products under Acetadote, Caldolor, Kristalose, Omeclamox, Vaprisol, Ethyol, Totect, Hepatoren, Boxaban, Vasculan Portaban and RediTrex brand names. Cumberland Pharma promotes approved products through its hospital and gastroenterology sales forces in the US. It is also establishing a network of international partners to bring its products to patients in their countries. Cumberland Pharma is headquartered in Nashville, Tennessee, the US.

Cumberland Pharmaceuticals Inc Key Recent Developments

Jun 05,2018: LSU Health New Orleans and Cumberland Emerging Technologies Announce Collaboration Agreement
May 08,2018: Cumberland Pharmaceuticals Reports First Quarter 2018 Financial Results
May 07,2018: Cumberland Pharmaceuticals Appoints New Senior Executive
Mar 06,2018: Cumberland Pharmaceuticals Reports 25% Revenue Growth For The Full Year 2017
Nov 07,2017: Cumberland Pharmaceutical Reports 27% Revenue Growth In The Third Quarter

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company


Section 1 - About the Company
Cumberland Pharmaceuticals Inc - Key Facts
Cumberland Pharmaceuticals Inc - Key Employees
Cumberland Pharmaceuticals Inc - Key Employee Biographies
Cumberland Pharmaceuticals Inc - Major Products and Services
Cumberland Pharmaceuticals Inc - History
Cumberland Pharmaceuticals Inc - Company Statement
Cumberland Pharmaceuticals Inc - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Section 2 – Company Analysis
Company Overview
Cumberland Pharmaceuticals Inc - Business Description
Business Segment: Acetadote (acetylcysteine)
Overview
Performance
Business Segment: Caldolor
Overview
Performance
Business Segment: Ethyol (amifostine)
Overview
Performance
Business Segment: Kristalose (lactulose)
Overview
Performance
Business Segment: Omeclamox
Overview
Performance
Business Segment: Totect
Overview
Performance
Business Segment: Vaprisol
Overview
Performance
R&D Overview
Cumberland Pharmaceuticals Inc - Corporate Strategy
Cumberland Pharmaceuticals Inc - SWOT Analysis
SWOT Analysis - Overview
Cumberland Pharmaceuticals Inc - Strengths
Cumberland Pharmaceuticals Inc - Weaknesses
Cumberland Pharmaceuticals Inc - Opportunities
Cumberland Pharmaceuticals Inc - Threats
Cumberland Pharmaceuticals Inc - Key Competitors
Section 3 – Company Financial Ratios
Financial Ratios - Capital Market Ratios
Financial Ratios - Annual Ratios
Performance Chart
Financial Performance
Financial Ratios - Interim Ratios
Financial Ratios - Ratio Charts
Section 4 – Company’s Lifesciences Financial Deals and Alliances
Cumberland Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018
Cumberland Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Type, 2012 to YTD 2018
Cumberland Pharmaceuticals Inc, Recent Deals Summary
Section 5 – Company’s Recent Developments
Jun 05, 2018: LSU Health New Orleans and Cumberland Emerging Technologies Announce Collaboration Agreement
May 08, 2018: Cumberland Pharmaceuticals Reports First Quarter 2018 Financial Results
May 07, 2018: Cumberland Pharmaceuticals Appoints New Senior Executive
Mar 06, 2018: Cumberland Pharmaceuticals Reports 25% Revenue Growth For The Full Year 2017
Nov 07, 2017: Cumberland Pharmaceutical Reports 27% Revenue Growth In The Third Quarter
Aug 08, 2017: Cumberland Pharmaceuticals Reports Double Digit Revenue Growth for the Fourth Consecutive Quarter
May 15, 2017: Cumberland Pharmaceuticals Reports Revenue Growth Of 25% In First Quarter 2017
Mar 07, 2017: Cumberland Pharmaceuticals Reports Fourth Quarter And Full Year 2016 Financial Results
Jan 16, 2017: Cumberland Pharmaceuticals Announces Kenneth J. Krogulski To Join Its Board Of Directors
Jan 16, 2017: Cumberland Pharmaceuticals Announces Kenneth J. Krogulski To Join Its Board Of Directors
Section 6 – Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer
List of Tables
Cumberland Pharmaceuticals Inc, Key Facts
Cumberland Pharmaceuticals Inc, Key Employees
Cumberland Pharmaceuticals Inc, Key Employee Biographies
Cumberland Pharmaceuticals Inc, Major Products and Services
Cumberland Pharmaceuticals Inc, History
Cumberland Pharmaceuticals Inc, Subsidiaries
Cumberland Pharmaceuticals Inc, Key Competitors
Cumberland Pharmaceuticals Inc, Ratios based on current share price
Cumberland Pharmaceuticals Inc, Annual Ratios
Cumberland Pharmaceuticals Inc, Annual Ratios (Cont...1)
Cumberland Pharmaceuticals Inc, Annual Ratios (Cont...2)
Cumberland Pharmaceuticals Inc, Interim Ratios
Cumberland Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018
Cumberland Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Type, 2012 to YTD 2018
Cumberland Pharmaceuticals Inc, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios
List of Figures
Cumberland Pharmaceuticals Inc, Performance Chart (2013 - 2017)
Cumberland Pharmaceuticals Inc, Ratio Charts
Cumberland Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018
Cumberland Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report